In this series, oncological responses evaluated using mRECIST criteria were similar at all time points for the two treatments, with the exception of objective response rate at 9–12 months, where DEE-b-TACE showed a trend of better oncological response and longer time to recurrence over DEE-TACE in patients presenting with larger tumors.
← all excerpts
Microballoon Interventions for Liver Tumors: Review of Literature and Future Perspectives.
1
—
—